Stay updated on Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial page.
Latest updates to the Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial page
- Check4 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4. No substantive content changes to study details or eligibility criteria are evident.SummaryDifference0.0%
- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedA dedicated Locations section was added listing study sites in Arizona and Minnesota, and the former separate Arizona Locations and Minnesota Locations subsections were removed.SummaryDifference0.3%
- Check55 days agoChange DetectedThis change is a minor revision update from v3.2.0 to v3.3.2 and does not modify study content, eligibility criteria, endpoints, or other user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check62 days agoChange DetectedRemoved the government funding status notice about potential data updates and delays on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check83 days agoChange DetectedNo substantive changes to core study information (eligibility, interventions, outcomes, or enrollment) are visible in the new screenshot; any differences appear cosmetic. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check105 days agoChange DetectedVersion bumped to v3.2.0 with an added government-operating-status notice; the previous v3.1.0 deletion indicates the page now reflects the updated version.SummaryDifference2%
Stay in the know with updates to Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Standard Therapy in Glioblastoma Clinical Trial page.